ArticleVeterinary world2026
Dietary curcumin encapsulated in nanostructured lipid carriers improves growth performance, feed utilization efficiency, and resistance to <em>Streptococcus agalactiae</em> in Nile tilapia (<em>Oreochromis niloticus</em>).
Article in Veterinary world, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Streptococcosis caused by Materials and Methods: CUR-NLCs were synthesized using a phase-inversion compositional technique and characterized for particle size, polydispersity index, zeta potential, encapsulation efficiency, and release behavior. A 60-day feeding trial was conducted using four dietary treatments: a control diet, a free CUR diet (2000 mg/kg feed), CUR-NLCs containing an equivalent amount of CUR, and blank nanostructured lipid carriers. Growth performance, feed utilization indices, hepatosomatic index, and length-weight relationships were evaluated. Antibacterial activity against Results: CUR-NLCs exhibited favorable physicochemical characteristics, including a mean particle size of 215.6 nm, a low polydispersity index (0.145), and a high encapsulation efficiency (98.79%), along with sustained-release properties. CUR-NLCs produced larger inhibition zones against Conclusion: Dietary administration of CUR encapsulated in nanostructured lipid carriers improved growth performance, feed utilization efficiency, and post-challenge survival of Nile tilapia. These findings demonstrate that CUR-NLCs represent a promising phytobiotic-based nutritional strategy for enhancing fish health and promoting sustainable tilapia aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.